Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Ebert

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Immunology and Cell Biology|June 27, 2024
Striking an alliance between T cells and macrophages for enhanced cancer immunotherapyTessa Gargett, Lisa M Ebert
Kidney International|November 28, 2013
Fos-icking for control of angiogenesis: increasing the longevity of peritoneal dialysisClaudine S Bonder, Lisa M Ebert
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytesLisa M Ebert, Shaun R McColl
Molecular Immunology|April 15, 2005
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissuesLisa M Ebert, Patrick Schaerli, Bernhard Moser
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillanceLisa M Ebert, Simone Meuter, Bernhard Moser
Clinical & Translational Immunology|May 30, 2019
Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastomaMichael P Brown, Lisa M Ebert, Tessa Gargett
Clinical & Translational Immunology|August 17, 2021
Erratum: Clinical chimeric antigen receptor T-cell therapy: a new and promising treatment modality for glioblastomaMichael P Brown, Lisa M Ebert, Tessa Gargett
Frontiers in Immunology|November 6, 2023
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastomaBryan Gardam, Tessa Gargett, Michael P Brown, et al.
Biochemical Society Transactions|March 16, 2018
Logic-gated approaches to extend the utility of chimeric antigen receptor T-cell technologyLisa M Ebert, Wenbo Yu, Tessa Gargett, et al.
Immunology and Cell Biology|September 11, 2023
Celebrating 100 years of Immunology & Cell Biology - a special focus on the field of tumor immunology in AustraliaSnehlata Kumari, Rachael M Zemek, Umaimainthan Palendira, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Immunology and Cell Biology|June 27, 2024
Striking an alliance between T cells and macrophages for enhanced cancer immunotherapyTessa Gargett, Lisa M Ebert
Kidney International|November 28, 2013
Fos-icking for control of angiogenesis: increasing the longevity of peritoneal dialysisClaudine S Bonder, Lisa M Ebert
Journal of Immunology (Baltimore, Md. : 1950)|December 26, 2001
Up-regulation of CCR5 and CCR6 on distinct subpopulations of antigen-activated CD4+ T lymphocytesLisa M Ebert, Shaun R McColl
Molecular Immunology|April 15, 2005
Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissuesLisa M Ebert, Patrick Schaerli, Bernhard Moser
Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
Homing and function of human skin gammadelta T cells and NK cells: relevance for tumor surveillanceLisa M Ebert, Simone Meuter, Bernhard Moser
Clinical & Translational Immunology|May 30, 2019
Clinical chimeric antigen receptor-T cell therapy: a new and promising treatment modality for glioblastomaMichael P Brown, Lisa M Ebert, Tessa Gargett
Clinical & Translational Immunology|August 17, 2021
Erratum: Clinical chimeric antigen receptor T-cell therapy: a new and promising treatment modality for glioblastomaMichael P Brown, Lisa M Ebert, Tessa Gargett
Frontiers in Immunology|November 6, 2023
Targeting the dendritic cell-T cell axis to develop effective immunotherapies for glioblastomaBryan Gardam, Tessa Gargett, Michael P Brown, et al.
Biochemical Society Transactions|March 16, 2018
Logic-gated approaches to extend the utility of chimeric antigen receptor T-cell technologyLisa M Ebert, Wenbo Yu, Tessa Gargett, et al.
Immunology and Cell Biology|September 11, 2023
Celebrating 100 years of Immunology & Cell Biology - a special focus on the field of tumor immunology in AustraliaSnehlata Kumari, Rachael M Zemek, Umaimainthan Palendira, et al.
Pageof 6